Source: Eur Respir Monogr 2014; 63: 184-204
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
Anja Kathrin Jaehne, Namita Jayaprakash, Gina Hurst, Steven Moore, Michael F. Harrison, Emanuel P. Rivers. Early recognition and treatment of severe sepsis and septic shock in CAP. Eur Respir Monogr 2014; 63: 184-204

Member's Comments

No comment yet.

Related content which might interest you: Compliance with severe sepsis bundles and its effect on outcomes of severe pneumonia and septic shock in a Chinese hospital Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Changes in the vascular platelet phase of hemostasis in patients with septic and traumatic shock, presenting ARDS Source: Eur Respir J 2004; 24: Suppl. 48, 264s Year: 2004 Adrenal insufficiency and relative eosinophilia in critically ill patients with septic shock due to ventilator-associated pneumonia (VAP) Source: Eur Respir J 2006; 28: Suppl. 50, 785s Year: 2006 Sepsis severity is an excellent predictor of mortality in pneumococcal pneumonia Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia Year: 2006 Adrenocortical state in critically ill infants and children with pnuemonia complicated by sepsis and septic shock Source: International Congress 2019 – Neonatal and paediatric intensive care Year: 2019 Non-antibiotic treatment for severe pneumonia? Source: Annual Congress 2005 - Outcome in severe pneumonia Year: 2005 The interconnection of severe pneumonia and sepsis Source: Eur Respir J 2004; 24: Suppl. 48, 548s Year: 2004 Prognostic value of Fas ligand in patients with sepsis and septic shock Source: International Congress 2019 – Biomarkers, laboratory findings and pre-clinical data in acute respiratory failure Year: 2019 Diaphragm function in patients with sepsis and septic shock. A longitudinal ultrasound study Source: Virtual Congress 2021 – COVID19, acute respiratory failure and basic science Year: 2021 Targeting coagulation activation in severe COVID-19 pneumonia: lessons from bacterial pneumonia and sepsis Source: Eur Respir Rev, 29 (157) 200240; 10.1183/16000617.0240-2020 Year: 2020 How I manage severe sepsis Source: Annual Congress 2010 - How I manage severe sepsis Year: 2010 Characterization of community acquired pneumonia (CAP) with severe sepsis at diagnosis Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Disseminated intravascular coagulation profiles in patients with septic shock on ECMO Source: International Congress 2016 – Diagnostic and therapeutic challenges in acute respiratory failure Year: 2016 Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2007; 30: Suppl. 51, 42s Year: 2007 Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia Source: Eur Respir J 2009; 33: 153-159 Year: 2009 Post-resuscitation central venous pressure and serum lactate associated with survival in severe sepsis and septic shock Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 The influence of inadequate starting empirical antimicrobial therapy of septic pneumonia on outcomes at patients with angiogenic sepsis Source: Eur Respir J 2004; 24: Suppl. 48, 549s Year: 2004 Plasma estradiol levels predict mortality in pneumonia related septic shock Source: Annual Congress 2009 - Acute lung injury and biomarkers Year: 2009